Does low ferritin cause hair loss, and should you take iron?
Whether low iron causes hair loss is unsettled. Some studies found lower average ferritin in women with hair loss, but a 2010 study with 76 comparison women found low ferritin no more often in women with hair loss, and in 2026 a study of 13,732 female patients with telogen effluvium found the same average ferritin as in matched patients without it. We found no randomised trial of iron on its own for hair loss, and no trial behind the ferritin targets of 40, 50 or 70 often quoted for hair. The American Academy of Dermatology says to take iron only when a blood test shows a deficiency, because too much can cause iron poisoning.
Is low iron more common in hair loss?
In a 2003 study, 52 women with pattern hair loss had a mean ferritin of 37.3 ng/mL (the same as µg/L), against 59.5 in 11 women without hair loss; women with telogen effluvium were not significantly lower. A 2022 meta-analysis pooled 18 studies comparing women with and without hair loss and also found lower average ferritin in those with it, but it compared blood levels and did not test iron. A 2010 study compared 381 women with pattern hair loss or chronic telogen effluvium with 76 women without hair loss. Among premenopausal women, ferritin of 15 or less was found in about 12% of those with hair loss and about 30% of those without. In 2026, a study in a large health-records database matched 13,732 female patients with telogen effluvium to 13,732 without it. In those whose ferritin was measured within 90 days, the mean was 73.2 ng/mL in both groups.
Does taking iron help?
We found no randomised trial of iron on its own for hair loss, in the medical literature or on ClinicalTrials.gov. In a 2002 study of 194 women with chronic shedding, 12 had ferritin of 20 or less. The five of them whose scalp biopsies were normal took iron until their ferritin passed 20, and none saw the hair loss stop or reverse. A 2022 study of 138 patients' records at a New York clinic found no statistically significant gain in hair density in deficient patients given supplements, compared with deficient patients who were not, after 141 days on average; iron, vitamin D, zinc and thyroid hormone were analysed together, and the authors note the small numbers and short follow-up. A 2006 review found insufficient evidence to give iron for hair loss to people who lack iron but are not anaemic. A 2010 review called for a well-designed trial in iron-deficient women. We found none since.
Where the 40, 50 and 70 targets come from
We found no trial that raised ferritin past any of these numbers and measured hair. The earliest source for 40 we found is a 1992 study of 40 premenopausal women with androgen-related thinning. Of the 20 given an anti-androgen hormone treatment, those with ferritin above 40 gained hair density significantly and those below did not. It did not test iron. A 2024 study chose 50 because it is close to average ferritin in women; among women given iron, 25 of 35 above 50 were rated "very satisfied" by their dermatologists, against 4 of 40 below, with no untreated group and no hair count. The 70, with a normal sedimentation rate (a marker of inflammation), was recommended by the 1992 study's author, who wrote in 2002 that the right level was "yet to be definitively established". In the 2010 study, a cut-off of 40 counted 72% of premenopausal women without hair loss as deficient.
What counts as low
Guidelines for diagnosing iron deficiency itself, rather than hair loss, use their own numbers. The World Health Organization's 2020 guideline uses ferritin below 15 for healthy adults and below 70 for people with infection or inflammation, which push ferritin up, and says inflammation markers should be measured alongside it. In 2026 the American Society of Hematology suggested 30 or less for adults, and said 50 or less is appropriate for people with symptoms of iron deficiency or ongoing risk factors such as heavy periods. In France, the HAS recommends ferritin as the first test, says a low result is enough to diagnose deficiency, adds iron and transferrin in rarer cases such as inflammation, and noted in 2011 that ferritin reference values vary between laboratories.
Should everyone with hair loss be tested?
Testing everyone with hair loss is disputed. The authors of the 2026 health-records study advise against routine tests in telogen effluvium when there are no other symptoms. The French Society of Dermatology's patient site says that in pattern hair loss checking iron stores can be useful, and the British Association of Dermatologists says telogen effluvium can come back if a possible underlying cause such as iron deficiency is not treated.
Safety
The American Academy of Dermatology warns that iron taken when levels are normal can be harmful, and that too much can cause iron poisoning. People with hereditary haemochromatosis absorb too much iron from food, risk overload and are advised to avoid iron supplements. The European Food Safety Authority could not set an upper limit and instead set a safe level of 40 mg a day in total for adults, food included; the US upper limit is 45 mg. Neither applies to iron taken under medical supervision to treat a deficiency. In the US, iron supplements sold as tablets or capsules must carry a warning that accidental overdose is a leading cause of fatal poisoning in children under 6. A 2006 review says the commonest causes of iron-deficiency anaemia before menopause are periods and pregnancy; in men and in women after menopause, doctors should look for blood loss, especially from the gut, including bowel cancer.
What guidelines and regulators say
The European S3 guideline on androgenetic alopecia found "insufficient evidence for iron supplementation in absence of iron deficiency". In 2014 the EU refused a health claim for iron worded "Excessive hair loss in non-menopausal women". The European Food Safety Authority had examined the five observational studies and one review submitted. Of the three studies it could draw conclusions from, two found no link between iron status and hair loss and one found a link, and it concluded that a cause and effect relationship had not been established. None of the claims the EU allows for iron mentions hair. The iron sulphate tablet we checked in the French medicines database is authorised for anaemia caused by iron deficiency and for preventing iron deficiency in pregnancy when diet falls short, not for hair loss. It needs no prescription, and its official product summary says checking whether it worked is useful only after three months of treatment, with blood tests.
Related questions
Sources
- Decreased serum ferritin is associated with alopecia in women · Journal of Investigative Dermatology, 2003 · PMID 14708596
- Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis · Skin Appendage Disorders, 2022 · PMID 35415182
- Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups · Journal of the American Academy of Dermatology, 2010 · PMID 20947203
- Broad laboratory testing does not show utility for telogen effluvium: A retrospective analysis of 22-million laboratory results using TriNetX · JAAD International, 2026 · PMID 41726102
- There is no clear association between low serum ferritin and chronic diffuse telogen hair loss · British Journal of Dermatology, 2002 · PMID 12410711
- Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities · JAAD International, 2022 · PMID 36147213
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss · Journal of the American Academy of Dermatology, 2006 · PMID 16635664
- Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle · Journal of the American Academy of Dermatology, 2010 · PMID 20888064
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women · Clinical Endocrinology, 1992 · PMID 1424176
- Iron Supplementation May Improve the Patient’s Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study · Indian Journal of Dermatology, 2024 · PMID 38841243
- Nutritional factors and hair loss · Clinical and Experimental Dermatology, 2002 · PMID 12190640
- WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations · World Health Organization, 2020
- ASH 2026 Guidelines on Diagnosis of Iron Deficiency: Visual Summary of Recommendations · American Society of Hematology, 2026
- Suspicion de carence en fer : quels examens prescrire ? · Haute Autorité de santé, 2011
- Connaitre les examens et traitements de l'alopécie androgénétique · Dermato-Info (Société Française de Dermatologie), 2026
- Telogen effluvium (a type of hairloss) · British Association of Dermatologists, 2025
- Hair loss: Diagnosis and treatment · American Academy of Dermatology, 2022
- Iron - Health Professional Fact Sheet · NIH Office of Dietary Supplements, 2025
- Scientific opinion on the tolerable upper intake level for iron · EFSA Journal, 2024
- S3 - European Dermatology Forum Guideline for the Treatment of Androgenetic Alopecia in Women and in Men · European Dermatology Forum, 2017
- Commission Regulation (EU) No 155/2014 of 19 February 2014 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health · European Commission, 2014
- Scientific Opinion on the substantiation of a health claim related to iron and maintenance of normal hair growth pursuant to Article 13(5) of Regulation (EC) No 1924/2006 · EFSA Journal, 2012
- Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health · European Commission, 2012
- TARDYFERON 80 mg, comprimé pelliculé · Base de données publique des médicaments (ANSM), 2024
Checked against its sources on 2026-10-29, by us, not by a doctor. A research register, not medical advice: talk to a dermatologist about your own case. See why we're not doctors.